Weight loss i.e., GLP-1 and GIP cut the intake and glucagon boosts calorie burn
The reasoning is that an empty stomach gives the GLP-1 receptor activation less material to slow down
Glucagon-like peptide-1 receptor Tie2 + cells are essential for the cardioprotective actions of liraglutide in mice with experimental myocardial infarction
These findings should be interpreted with caution, since this study is subject to potential confounding, as lifestyle modifications during the 6-month period, such as changes in diet, physical activity, or medication adherence, may have influenced stem cell characteristics independently of semaglutide treatment [58]
Nat Protoc 8:24712482
Rizzo, The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction, Diabetes Metabolic Syndrome and Obesity